MYC and triple-negative breast carcinoma: FAO inhibition can reduce the energy metabolism and suppress tumorigenesis in MYC‐high expressed triple negative breast cancer (TNBC), suggesting that MYC could serve as a biomarker for determining which patients may benefit from FAO inhibition therapy.110